BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3089005)

  • 1. Review of epidemic aminoglycoside resistance worldwide.
    Mayer KH
    Am J Med; 1986 Jun; 80(6B):56-64. PubMed ID: 3089005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
    Phillips I; King A; Shannon K
    Am J Med; 1986 Jun; 80(6B):48-55. PubMed ID: 3728534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of aminoglycoside resistance patterns.
    Legakis NJ; Velonaki A; Velonakis EM; Lymberopoulou T
    Chemioterapia; 1986 Jun; 5(3):185-90. PubMed ID: 3087636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion.
    Miró E; Grünbaum F; Gómez L; Rivera A; Mirelis B; Coll P; Navarro F
    Microb Drug Resist; 2013 Apr; 19(2):94-9. PubMed ID: 23206280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 11. Transferable amikacin resistance in gram-negative bacterial isolates.
    Kallová J; Macicková T; Majtánová A; Aghová A; Adam D; Kettner M
    Chemotherapy; 1995; 41(3):187-92. PubMed ID: 7656664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amikacin resistance of clinical strains of Enterobacteriaceae and Pseudomonas].
    Moreva TV; Anisimova LA; Erova TE; Boronin AM
    Antibiot Khimioter; 1992 Apr; 37(4):25-8. PubMed ID: 1417311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside resistance among blood culture isolates.
    Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
    J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
    Ghotaslou R; Yeganeh Sefidan F; Akhi MT; Asgharzadeh M; Mohammadzadeh Asl Y
    Microb Drug Resist; 2017 Oct; 23(7):826-832. PubMed ID: 28151044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K; Abu-Hasan N; Al-Asmar H
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.
    Weinstein RA; Nathan C; Gruensfelder R; Kabins SA
    J Infect Dis; 1980 Mar; 141(3):338-45. PubMed ID: 6767795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of gentamicin resistance in nosocomial infections.
    John JF; Rubens CE; Farrar WE
    Am J Med Sci; 1980; 279(1):25-30. PubMed ID: 6768292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
    Ronco E; Migueres ML; Vacheron F; Guenounou M
    Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.